Stephen Machatha

Track

Insider profile

Currently holds a position at Aldeyra Therapeutics Inc

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -30% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Senior Vice President, Technical Operations Aldeyra Therapeutics Inc Jan. 15, 2019 -
Stephen Machatha's trades of Aldeyra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
289.08
Quantity 83,051
Value US$3,909,672
Transaction date
Proposed sale
Price
5.10
Quantity 16,041
Value US$81,809
Transaction date
Proposed sale
Price
3.16
Quantity 11,537
Value US$36,502
Transaction date
Proposed sale
Price
3.62
Quantity 18,231
Value US$65,996
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-12 2025-08-12
PrS Proposed sale
83,051
289.08
US$3,909,672 		83,051 289.08 US$3,909,672
2025-08-13 2025-08-11
PlS Planned sale
10,994 -13.7%
72.69
US$1,445,340 		10,994 -13.7% 72.69 US$1,445,340
2024-08-14 2024-08-12
S Sale
10,445 -39.9%
243.59
US$1,692,407 		10,445 -39.9% 243.59 US$1,692,407
2024-08-12 2024-08-12
PrS Proposed sale
16,041
5.10
US$81,809 		16,041 5.10 US$81,809
2024-03-12 2024-03-12
PrS Proposed sale
11,537
3.16
US$36,502 		11,537 3.16 US$36,502
2024-03-12 2024-03-12
S Sale
11,537 -4.5%
3.16
US$36,503 		11,537 -4.5% 3.16 US$36,503
2024-03-12 2024-03-11
S Sale
18,231 -6.7%
3.41
US$62,102 		18,231 -6.7% 3.41 US$62,102
2024-03-11 2024-03-11
PrS Proposed sale
18,231
3.62
US$65,996 		18,231 3.62 US$65,996